Seagen Inc.
HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER

Abstract:

Methods for using anti-LIV1 antibodies and antibody-drug conjugates, including anti-LIV1 antibody-drug conjugates, to inhibit proliferation of a cell, as well as for the treatment of cancers, such as, e.g., prostate cancer and melanoma, are provided.